| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |